SCHEMBL7795969

SCHEMBL7795969

CC(C)(CC(=O)N[C@@H]1CSc2ccccc2N(Cc2ccc(-c3ccccc3CNC(=O)NCCO)cc2)C1=O)NC[C@H](O)CO

nearest known ligand 0.57

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 4/20 0.57
XIAP P98170 2/20 0.40
AGTR1 P30556 1/20 0.39
F7 P08709 5/20 0.39
F3 P13726 5/20 0.39
F2 P00734 2/20 0.39
ACE P12821 4/20 0.35
MME P08473 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7794660 0.95 GHSR (0.56) GHSRXIAPAGTR1F7F3
SCHEMBL7792142 0.94 GHSR (0.55) GHSRXIAPAGTR1F7F3
SCHEMBL7785962 0.94 GHSR (0.57) GHSRXIAPAGTR1F7F3
SCHEMBL7794426 0.93 GHSR (0.52) GHSRXIAPAGTR1F7F3
SCHEMBL7785909 0.92 GHSR (0.48) GHSRXIAPAGTR1F7F3
SCHEMBL7785950 0.92 GHSR (0.51) GHSRXIAPAGTR1F7F3
SCHEMBL8331115 0.91 GHSR (0.46) GHSRXIAPAGTR1F7F3
SCHEMBL8331169 0.91 GHSR (0.51) GHSRXIAPAGTR1F7F3
SCHEMBL7796095 0.91 GHSR (0.51) GHSRXIAPAGTR1F7F3
SCHEMBL7792083 0.89 GHSR (0.64) GHSRXIAPAGTR1F7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0659179-B1 BENZO-FUSED LACTAMS PROMOTE RELEASE OF GROWTH HORMONE MERCK & CO INC (US) 2001-11-21 EP claimed
US-5968924-A HAVE THE ABILITY TO STIMULATE THE RELEASE OF NATURAL OR ENDOGENOUS GROWTH HORMONE; TREATMENT OF OBESITY, OSTEOPOROSIS MERCK & CO., INC. (US) 1999-10-19 US claimed
WO-1994005634-A1 BENZO-FUSED LACTAMS PROMOTE RELEASE OF GROWTH HORMONE MERCK & CO., INC. (US) 1994-03-17 WO claimed
US-5968924-A HAVE THE ABILITY TO STIMULATE THE RELEASE OF NATURAL OR ENDOGENOUS GROWTH HORMONE; TREATMENT OF OBESITY, OSTEOPOROSIS MERCK & CO., INC. (US) 1999-10-19 US disclosed